Dr. Virginia Reddy, MD
What this data tells you about Dr. Reddy
Dr. Virginia Reddy is a rheumatology specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Reddy performed 41,602 Medicare services across 1,824 unique beneficiaries.
Between the years covered by Open Payments, Dr. Reddy received a total of $8,312 from 33 pharmaceutical and/or device companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Reddy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 38,000 | $4 | $15 |
| Sed rate test (inflammation marker) | 434 | $3 | $8 |
| C-reactive protein test (inflammation marker) | 433 | $5 | $16 |
| Complete blood count (CBC) with differential | 415 | $7 | $23 |
| Office visit, established patient (30-39 min) | 415 | $89 | $378 |
| Blood draw (venipuncture) | 408 | $8 | $27 |
| Comprehensive metabolic blood panel | 403 | $10 | $32 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 204 | $59 | $218 |
| Office visit, established patient, complex (40-54 min) | 110 | $130 | $530 |
| Vitamin D level test | 88 | $27 | $89 |
| Uric acid level test | 57 | $4 | $14 |
| Measurement of complement (immune system proteins), antigen, | 56 | $11 | $36 |
| Automated urinalysis | 52 | $2 | $7 |
| Urinalysis with microscopic exam | 35 | $3 | $10 |
| Screening test for autoimmune disorder | 35 | $12 | $36 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 33 | $17 | $54 |
| Measurement of antibody for rheumatoid arthritis assessment | 30 | $12 | $39 |
| Drug screening test | 28 | $61 | $186 |
| Screening test for antibody to noninfectious agent | 28 | $11 | $36 |
| Lipid panel (cholesterol and triglycerides) | 27 | $11 | $40 |
| Creatine kinase (cardiac enzyme) level, total | 27 | $6 | $20 |
| Rheumatoid factor level | 27 | $5 | $17 |
| New patient office visit (45-59 min) | 27 | $123 | $491 |
| Ferritin level test (iron stores) | 24 | $13 | $41 |
| Hepatitis b surface antibody measurement | 24 | $11 | $32 |
| Hepatitis b core antibody measurement | 23 | $12 | $36 |
| Hepatitis c antibody measurement | 23 | $14 | $43 |
| Detection test by immunoassay technique for hepatitis b surface antigen | 23 | $10 | $31 |
| Thyroid stimulating hormone (TSH) test | 22 | $16 | $50 |
| Iron level test | 19 | $6 | $19 |
| Iron binding capacity test | 19 | $8 | $26 |
| Flu vaccine administration | 19 | $30 | $80 |
| Flu vaccine, high-dose | 18 | $72 | $587 |
| Office visit, established patient (20-29 min) | 16 | $59 | $267 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Reddy is a mixed practice specialist, with above-average Medicare volume (top 25% in TX), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Reddy experienced with certolizumab injection (cimzia)?
Does Dr. Reddy receive payments from pharmaceutical companies?
How do Dr. Reddy's costs compare to other rheumatologists in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology